Cite
APA Citation
Berthon, C., Raffoux, E., Thomas, X., Vey, N., Gomez-Roca, C., Yee, K., Taussig, D. C., Rezai, K., Roumier, C., Herait, P., Kahatt, C., Quesnel, B., Michallet, M., Recher, C., Lokiec, F., Preudhomme, C., & Dombret, H. (2016). bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. Lancet, 3(4), e186–e195. http://access.bl.uk/ark:/81055/vdc_100054580877.0x00000c